Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Movement Disorders

• Publication date

  1998-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.870130130PMID 9452343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reply from the Authors

  1996cited by this paper
• Action myoclonus as an early clinical sign of carcinomatous meningitis

  1996cited by this paper
• Improvement of both tardive dystonia and akathisia after botulinum toxin injection.

  1996cited by this paper
• Tardive syndromes and other drug-induced movement disorders.

  1995cited by this paper
• Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.

  1994cited by this paper
• [Tardive dystonia].

  1992cited by this paper
• Therapeutic uses of botulinum toxin.

  1991cited by this paper
• Botulinum toxin injections for cervical dystonia

  1990cited by this paper
• Ca2+ influx insensitive to organic Ca2+ entry blockers contributes to noradrenaline-induced contractions of the isolated guinea pig aorta.

  1990cited by this paper
• A comparison of severe tardive dystonia and severe tardive dyskinesia

  1989cited by this paper
• Tardive dystonia.

  1988cited by this paper
• Tardive dystonia in a psychiatric hospital.

  1987cited by this paper
• Torticollis

  1891cited by this paper

• Prolonged Tardive Dyskinesia Induced by Long-Acting Paliperidone Palmitate in Schizophrenia: A Case Report

  2025cites this paper
• Tardive Syndromes: A Challenging Multitude of Maladies

  2025cites this paper
• Treatment of tardive dystonia: A review

  2023cites this paper
• Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up

  2022cites this paper
• Schizophrenia and Related Psychoses

  2021cites this paper
• Management of Tardive Syndrome: Medications and Surgical Treatments

  2020cites this paper
• The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder.

  2019cites this paper
• The Symptomatic Treatment of Acquired Dystonia: A Systematic Review

  2016cites this paper
• Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia

  2014cites this paper
• Treatment of cervical dystonia

  2013cites this paper
• Threshold of Clinical Severity of Cervical Dystonia for Positive 18F-FDG PET/CT

  2013cites this paper
• Parkinson's disease: treatment and non-motor features

  2012cites this paper
• Dystonien mit Beteiligung der mastikatorischen Muskulatur : eine retrospektive Analyse

  2011cites this paper
• Tardive movement disorders: a practical approach

  2011cites this paper
• Increased Muscle Tone as a Cause of Muscle Pain

  2010cites this paper
• Muscle Pain: Understanding the Mechanisms

  2010cites this paper
• Spectrum of tardive syndromes: clinical recognition and management

  2010cites this paper
• Current clinical applications of botulinum toxin.

  2009cites this paper
• Neuroleptic-Induced Tardive Cervical Dystonia: Clinical Series of 20 Patients

  2009cites this paper
• Antipsychotic-induced extrapyramidal symptoms and their management

  2008cites this paper
• Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.

  2008cites this paper
• Use of Botulinum Toxin A in Adult Neurological Disorders

  2008cites this paper
• Botulinum Toxin Seroype A for Cervical Dystonia—An Assessment

  2008influential citation
• Botulinum Toxin in Movement Disorders

  2007cites this paper
• Drug-Induced Dystonia

  2006cites this paper
• Tardive dystonia

  2005cites this paper
• Drug-induced movement disorders in children and adolescents

  2005cites this paper
• The safety and tolerability of botulinum toxins for the treatment of cervical dystonia

  2005cites this paper
• Objective assessment of motor slowness in Huntington's disease: Clinical correlates and 2‐year follow‐up

  2004cites this paper
• Botulinum toxin A for the treatment of cervical dystonia

  2004cites this paper
• Treatment of cervical dystonia with botulinum toxin

  2004cites this paper
• Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.

  2003cites this paper
• Drug-induced movement disorders in children.

  2003cites this paper
• CLASSIFICATION AND TREATMENT OF TARDIVE SYNDROMES

  2003cites this paper
• [Extrapyramidal effects of antipsychotic drugs].

  2003cites this paper
• Drug-induced movement disorders.

  2002cites this paper
• Morphine in tardive and idiopathic dystonia

  2001cites this paper
• Botulinum toxin for the treatment of cervical dystonia

  2001cites this paper
• Morphine in tardive and idiopathic dystonia (short communication).

  2001cites this paper
• Cervical dystonia severity scale reliability study

  2001cites this paper
• The current status and use of botulinum toxins

  2001cites this paper
• Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: a retrospective chart review.

  2000cites this paper
• Antipsychotic-Induced Movement Disorders in the Elderly

  2000cites this paper
• Use of botulinum toxin type A in the treatment of cervical dystonia.

  2000cites this paper
• Tardive dyskinesia

  2000cites this paper
• Botulinum toxin in motor disorders.

  1999cites this paper
• Recent advances in the drug treatment of Parkinson's disease.

  1999cites this paper
• Tardive dystonia.

  1999cites this paper
• Imitators of Epilepsy

  1997cites this paper